XML 22 R10.htm IDEA: XBRL DOCUMENT v3.20.2
Exit and disposal activities
9 Months Ended
May 31, 2020
Restructuring and Related Activities [Abstract]  
Exit and disposal activities Exit and disposal activities
Transformational Cost Management Program
On December 20, 2018, the Company announced a transformational cost management program that was expected to deliver in excess of $1.0 billion of annual cost savings by fiscal 2022 (the “Transformational Cost Management Program”). As of the date of this report, the Company expects annual cost savings to be in excess of $2.0 billion by fiscal 2022, an increase from the previously reported expectations of annual cost savings in excess of $1.8 billion in October 2019 and $1.5 billion in April 2019. The Transformational Cost Management Program, which is multi-faceted and includes divisional optimization initiatives, global smart spending, global smart organization and the transformation of the Company’s information technology (IT) capabilities, is designed to help the Company achieve increased cost efficiencies. To date, the Company has taken actions across all aspects of the Transformational Cost Management Program. The actions under the Transformational Cost Management Program focus on all reportable segments and the Company’s global functions. Divisional optimization within each of the Company’s segments includes activities such as optimization of stores which includes plans to close approximately 200 Boots stores in the United Kingdom and approximately 200 stores in the United States.

The Company currently estimates that the Transformational Cost Management Program will result in cumulative pre-tax charges to its GAAP financial results of approximately $2.1 billion to $2.4 billion, of which $1.8 billion to $2.1 billion are expected to be recorded as exit and disposal activities. In addition to these impacts, as a result of the actions related to store closures taken under the Transformational Cost Management Program, the Company recorded $508 million of transition adjustments to decrease retained earnings due to the adoption of the new lease accounting standard (Topic 842) that became effective on September 1, 2019. See note 17, new accounting pronouncements, for additional information.

Since the inception of the Transformational Cost Management Program to May 31, 2020, the Company has recognized cumulative pre-tax charges to its financial results in accordance with GAAP of $899 million, which were primarily recorded within selling, general and administrative expenses. These charges included $209 million related to lease obligations and other real estate costs, $305 million in asset impairments, $293 million in employee severance and business transition costs and $92 million of information technology transformation and other exit costs.

Costs related to exit and disposal activities under the Transformational Cost Management Program for the three and nine months ended May 31, 2020 and May 31, 2019 were as follows (in millions):

Three months ended May 31, 2020Retail Pharmacy USARetail Pharmacy InternationalPharmaceutical WholesaleWalgreens Boots Alliance, Inc.
Lease obligations and other real estate costs1
$170  $ $—  $173  
Asset impairments19  10   30  
Employee severance and business transition costs51    57  
Information technology transformation and other exit costs21  13  —  34  
Total pre-tax exit and disposal costs$261  $27  $ $294  
1Includes $153 million of impairments relating to operating lease right-of-use and finance lease assets.
Nine months ended May 31, 2020Retail Pharmacy USARetail Pharmacy InternationalPharmaceutical WholesaleWalgreens Boots Alliance, Inc.
Lease obligations and other real estate costs1
$179  $ $ $184  
Asset impairments31  13   45  
Employee severance and business transition costs124  32  12  168  
Information technology transformation and other exit costs37  30   70  
Total pre-tax exit and disposal costs$371  $80  $17  $467  

1Includes $153 million of impairments relating to operating lease right-of-use and finance lease assets.

Three months ended May 31, 2019Retail Pharmacy USARetail Pharmacy InternationalPharmaceutical WholesaleWalgreens Boots Alliance, Inc.
Asset impairments$ $16  $11  $32  
Employee severance and other exit costs  11  24  
Total pre-tax exit and disposal costs$13  $21  $22  $56  

Nine months ended May 31, 2019Retail Pharmacy USARetail Pharmacy InternationalPharmaceutical WholesaleWalgreens Boots Alliance, Inc.
Asset impairments$ $48  $96  $149  
Employee severance and other exit costs24  39  22  86  
Total pre-tax exit and disposal costs$29  $88  $119  $235  


The changes in liabilities and assets related to the exit and disposal activities under Transformational Cost Management Program include the following (in millions):

Lease obligations and other real estate costsAsset ImpairmentsEmployee severance and business transition costsInformation technology transformation and other exit costsTotal
Balance at August 31, 2019$17  $—  $57  $ $78  
Costs184  45  168  70  467  
Payments(27) —  (92) (31) (151) 
Other1
(153) (45)  (13) (205) 
ASC 842 Leases adoption2
(4) —  —  —  (4) 
Currency—  —  —  —  —  
Balance at May 31, 2020$17  $—  $140  $29  $186  

1Includes $153 million of impairments relating to operating lease right-of-use and finance lease assets. Refer to note 4, leases for additional information.
2Represents liability for facility closings and related lease termination charges recorded as an offset to right-of-use assets upon the adoption of ASC 842. Refer to note 4, leases and note 17, new accounting pronouncements for additional information.

Store Optimization Program
On October 24, 2017, the Company’s Board of Directors approved a plan to implement a program (the “Store Optimization Program”) to optimize store locations through the planned closure of approximately 600 stores and related assets within the Company’s Retail Pharmacy USA segment upon completion of the acquisition of certain stores and related assets from Rite Aid. The Company continues to expect to close approximately 750 stores and related assets, of which substantially all have been closed as part of this program. The actions under the Store Optimization Program commenced in March 2018 and are
substantially completed with remaining activities expected to complete by end of fiscal 2020. The Store Optimization Program is expected to result in cost savings of approximately $350 million per year to be fully delivered by the end of fiscal 2020.

The Company currently estimates that it will recognize cumulative pre-tax charges to its GAAP financial results of approximately $375 million, compared to the Company's previously stated expectation of $400 million in April 2020, of which $345 million have been recorded to date, primarily within selling, general and administrative expenses. The Company expects to incur charges of approximately $185 million for lease obligations and other real estate costs, of which $162 million have been recorded to date and approximately $190 million for employee severance and other exit costs of which $183 million have been recorded to date. The Company estimates that substantially all of these cumulative pre-tax charges will result in cash expenditures.

Costs related to the Store Optimization Program for the three and nine months ended May 31, 2020 and May 31, 2019 were as follows (in millions):

Three months ended May 31,Nine months ended May 31,
2020201920202019
Lease obligations and other real estate costs1
$ $44  $24  $45  
Employee severance and other exit costs  25  54  
Total costs$10  $49  $49  $99  
1Includes $13 million operating lease right-of-use impairments for the nine months ended May 31, 2020.

The changes in liabilities related to the Store Optimization Program include the following (in millions):

Lease obligations and other real estate costsEmployee severance and other exit costsTotal
Balance at August 31, 2019$407  $22  $429  
Costs24  25  49  
Payments(32) (34) (67) 
Other1
(13) (8) (21) 
ASC 842 Leases adoption2
(378) —  (378) 
Balance at May 31, 2020$ $ $12  

1Includes $13 million operating lease right-of-use impairments for the nine months ended May 31, 2020. Refer to note 4, leases for additional information.
2Represents liability for facility closings and related lease termination charges recorded as an offset to right-of-use assets upon the adoption of ASC 842. Refer to note 4, leases and note 17, new accounting pronouncements for additional information.

Cost Transformation Program
On April 8, 2015, the Walgreens Boots Alliance Board of Directors approved a plan to implement a restructuring program (the “Cost Transformation Program”) as part of an initiative to reduce costs and increase operating efficiencies. The Cost Transformation Program implemented and built on the cost-reduction initiative previously announced by the Company on August 6, 2014 and included plans to close stores across the United States; reorganize corporate and field operations; drive operating efficiencies; and streamline information technology and other functions. The actions under the Cost Transformation Program focused primarily on the Retail Pharmacy USA segment, but included activities from all segments. The Company completed the Cost Transformation Program in the fourth quarter of fiscal 2017.

The liabilities related to the Cost Transformation Program declined by $382 million representing liability for facility closings and related lease termination charges recorded as an offset to right-of-use assets upon the adoption of ASC 842 on September 1, 2019. The remaining liabilities as of May 31, 2020 were not material.